Skip to main content

Table 2 Selection of hormone therapy and chemotherapy

From: The mode of progressive disease affects the prognosis of patients with metastatic breast cancer

 Oral 5FU 62
 Taxane 47
 Anthracycline 17
 Vinorelbine 17
 Eribulin 12
 Paclitaxel + Bevacizumab 11
 Targeted drug alone 9
 Others 26
Hormone therapy
 Non-steroidal AI 66
 Steroidal AI 36
 SERM 52
 MPA 6
  1. AI aromatase inhibitor, SERM selective estrogen receptor modulator, SERD selective estrogen receptor down-regulator, MPA medroxyprogesterone 17-Acetate